DENGUE FEVER PROFORMA Revised: October 2022 Patient’s Information Patient’s Name: ___________________________ Father’s Name: ____________________________________ Age: ____________________________________ Contact No: ______________________________________ Address: ___________________________________________________________________________________ CNIC No: Date of Admission Hospital Reg No: Dengue Patient Diagnosis Algorithm Fill in “DEAG Form O/R” Send Confirmatory Test for Dengue and manage accordingly Fever < 5 days Fever > 5 days IgM NS1 ‐ + + Dengue Fever After 24 hours Repeat NS1 and get IgM ‐ If Dengue suspicion is still High then After 48 hours Repeat IgM and get IgG Fill in Appropriate DEAG FORMS If ‐ve Repeat IgG after 48 hours Monitoring as per DEAG Guidelines If all above are ‐ve, Consider Non‐Dengue Plasma Leak Fill in “DEAG DF Form – 2” (48 hours data) No Plasma Leak Discharge according to “DEAG Discharge Criteria” Revised October, 2022 Attach cardiac monitor to patient Monitor: BP, PP, HR & RR Fluid resuscitation with isotonic crystalloid 10 ml/kg over 1 hour (500ml in adult of 50kg or above) Repeat second bolus of 10ml/kg if no improvement with previous bolus Send Baseline CBC, HCT, LFTs, S.Alb, B. Urea, S. Creatinine, NA+ K+ Ca++, ABG/VBG, Glucose, Blood Grouping & Cross Match Continue with fluid management while awaiting HCT result Consider Acidosis Bleeding Hypocalcemia Hypoglycemia Myocarditis Acidosis Bleeding Hypocalcemia Hypoglycemia Myocarditis Send ABGS CBC S.Calcium Blood Glucose ECG NaHCO3 - 1ml/kg (max 10ml) diluted in equal volume of Saline in a slow infusion PCV - 5ml/kg or whole blood - 10ml/kg 10% calcium gluconate - 1ml/kg (max 10ml) diluted in equal volume of Saline in a slow infusion IV Dextrose 10% Consider inotropic support Administer Colloid Infusion 10ml/kg over 1 hour Maximum ALGORITHM FOR THE DECLARATION OF DENGUE DEATH IN HOSPITAL Date & Time of Admission: ____________________ Date and Time of Death: _____________________ DEAG Forms filled properly: _____________________________________________________________ First Step: Initial review Platelet count less than 150,000 + Fever + Clinical Symptoms (Two (02) or more symptoms) Severe backache or joint pains Severe headache Rash on body Retroorbital pain Bleeding from nose, gums, cough, vomiting Severe muscular pain Severe stomachache Decreased urine frequency in children Second Step: Diagnosis Confirmed: _______________________________________________________ NS1/PCR with date: ______________________________________________________________ Dengue IGM with date: __________________________________________________________ Third Step: Results of following tests if performed 1: CBC, 2: LFT, 3: RFTs, 4: VBG/ABG 4: Ultrasound abdomen, 5: Chest X‐ray. Fourth Step: Additional Information regarding Co‐Morbidities. 1. ____________________________________________________________________________ 2. ____________________________________________________________________________ Fifth Step: Management of patient Monitored and managed as per DEAG guidelines for Signs of Plasma Leak Narrowing of pulse pressure < 20 mm ________________________________________ CRFT > 2 secs ____________________________________________________________ Tender hepatomegaly (DHF likely) ___________________________________________ No Urine output over the last 6 hours _________________________________________ Amount of fluids infused: _________________________________________________________ Dextran used or not and Amount: __________________________________________________ Causes of refractory shock sought or not: Acidosis, Bleeding, Hypocalcemia, Hypoglycemia, Myocarditis, Addisonian crisis: _____________________________________________________ Blood transfused or not: __________________________________________________________ Sixth Step: Seen by consultant or not: ______________________________________________________ Final Step: Cause of Death: 1: Due to Complication of Dengue_______________________________ 2: Due to Co morbidity ________________________________________ Comments by mortality review Committee: ________________________________________________ _____________________________________________________________________________________ _____________________________________________________________________________________ Mortality Review completed by: 1: _________________________________________ 2: _________________________________________ 3: _________________________________________ Hospital: __________________ __________________________ Date/Time: ________________ Revised: October 2022 Patient Name/Age/Gender: ______________________________________________________________